Literature DB >> 15155247

ELVIRA HSV, a yield reduction assay for rapid herpes simplex virus susceptibility testing.

Ruzena Stránská1, Rob Schuurman, David R Scholl, Joseph A Jollick, Carl J Shaw, Caroline Loef, Merjo Polman, Anton M van Loon.   

Abstract

A colorimetric yield reduction assay, ELVIRA (enzyme-linked virus inhibitor reporter assay) HSV, was developed to determine the antiviral drug susceptibilities of herpes simplex virus (HSV). It uses an HSV-inducible reporter cell line. This simple and rapid assay has an objective readout, low inoculum size, and good reproducibility. The results correlate well with those of the plaque reduction assay.

Mesh：

Substances：

Year:  2004        PMID： 15155247      PMCID： PMC415590          DOI： 10.1128/AAC.48.6.2331-2333.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  A rapid assay to screen for drug-resistant herpes simplex virus.

Authors:  P Tebas; D Scholl; J Jollick; K McHarg; M Arens; P D Olivo
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

2.  Antiviral susceptibility testing with a cell line which expresses beta-galactosidase after infection with herpes simplex virus.

Authors:  P Tebas; E C Stabell; P D Olivo
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

3.  Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients.

Authors:  S Safrin; T Elbeik; L Phan; D Robinson; J Rush; A Elbaggari; J Mills
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

4.  Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.

Authors:  Y Chen; C Scieux; V Garrait; G Socié; V Rocha; J M Molina; D Thouvenot; F Morfin; L Hocqueloux; L Garderet; H Espérou; F Sélimi; A Devergie; G Leleu; M Aymard; F Morinet; E Gluckman; P Ribaud
Journal:  Clin Infect Dis       Date:  2000-10-10       Impact factor: 9.079

Review 5.  Herpes simplex virus resistance to antiviral drugs.

Authors:  Florence Morfin; Danielle Thouvenot
Journal:  J Clin Virol       Date:  2003-01       Impact factor: 3.168

6.  Isolation of a cell line for rapid and sensitive histochemical assay for the detection of herpes simplex virus.

Authors:  E C Stabell; P D Olivo
Journal:  J Virol Methods       Date:  1992-08       Impact factor: 2.014

7.  Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.

Authors:  C Danve-Szatanek; M Aymard; D Thouvenot; F Morfin; G Agius; I Bertin; S Billaudel; B Chanzy; M Coste-Burel; L Finkielsztejn; H Fleury; T Hadou; C Henquell; H Lafeuille; M E Lafon; A Le Faou; M C Legrand; L Maille; C Mengelle; P Morand; F Morinet; E Nicand; S Omar; B Picard; B Pozzetto; J Puel; D Raoult; C Scieux; M Segondy; J M Seigneurin; R Teyssou; C Zandotti
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

8.  Sequential switching of DNA polymerase and thymidine kinase-mediated HSV-1 drug resistance in an immunocompromised child.

Authors:  Růzena Stránská; Anton M van Loon; Robbert G M Bredius; Merjo Polman; Elske Nienhuis; Matthias F C Beersma; Arjan C Lankester; Rob Schuurman
Journal:  Antivir Ther       Date:  2004-02

9.  Survey of resistance of herpes simplex virus to acyclovir in northwest England.

Authors:  J Christophers; J Clayton; J Craske; R Ward; P Collins; M Trowbridge; G Darby
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191
  9 in total
  5 in total

1.  Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.

Authors:  Sonia Burrel; Claire Deback; Henri Agut; David Boutolleau
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

Review 2.  Strategies for antiviral screening targeting early steps of virus infection.

Authors:  Tao Peng
Journal:  Virol Sin       Date:  2010-07-28       Impact factor: 4.327

3.  Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay.

Authors:  Yoshiko Fukui; Keiko Shindoh; Yumiko Yamamoto; Shin Koyano; Isao Kosugi; Toyofumi Yamaguchi; Ichiro Kurane; Naoki Inoue
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

4.  Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxviruses.

Authors:  Nadejda Valiaeva; Mark N Prichard; R Mark Buller; James R Beadle; Caroll B Hartline; Kathy A Keith; Jill Schriewer; Julissa Trahan; Karl Y Hostetler
Journal:  Antiviral Res       Date:  2009-10-01       Impact factor: 5.970

5.  A cell-based high-throughput approach to identify inhibitors of influenza A virus.

Authors:  Qian Gao; Zhen Wang; Zhenlong Liu; Xiaoyu Li; Yongxin Zhang; Zhizhen Zhang; Shan Cen
Journal:  Acta Pharm Sin B       Date:  2014-07-14       Impact factor: 11.413
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.